SNPX Message Board Post 9839828 | Synaptogenix Inc.
home / stock / snpx / snpx message board
rsimons48
(investorshub)
Posted on: Feb/27/2023 13:05:11
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171305831
At Mayo, the test may have been this:
News, Short Squeeze, Breakout and More Instantly...
-
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis PR Newswire Collaborative study will evaluate drug's potential to improve synaptic health and cognitive function in MS patients NEW YORK , ...
-
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery PR Newswire Proposed Schedule III drug classification expected to de-risk Cannasoul's cannabis research and potential regulatory pathways ...